Reports
Reports
Sale
The global transcranial magnetic stimulator market size was valued at USD 1.24 billion in 2023, driven by the increasing prevalence of neurological disorders, like schizophrenia, the rising geriatric population, resulting in an increase in age-related brain disorders. The market is anticipated to grow at a CAGR of 12.7% during the forecast period 2024-2032 to reach a value of USD 3.54 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry growth is driven by a higher prevalence of neurological diseases like Alzheimer's and Parkinson's (PD). The rising awareness of transcranial magnetic stimulator among professionals has increased the industry growth.
Transcranial magnetic stimulation or TMS refers to a non-invasive brain stimulation technique that uses a certain brain area with magnet induction forces. Electromagnetic induction is produced by electricity from a bow, and these pulses pass through the cranium in its specified brain receptor area. There are many different ways for brain stimulation, like electroconvulsive therapy and brain stimulation techniques; however, the most commonly used approach for brain stimulation is the currently transcranial magnetic stimulation technique.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the industry can be divided into:
The industry can be broadly categorised based on its applications into:
The EMR report looks into the regional markets of transcranial magnetic stimulator like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The main drivers anticipated in the transcranial magnetic stimulator market include the increasing prevalence of neurological disorders, like schizophrenia and other disorders, the rising geriatric population, resulting in an increase in age-related brain disorders, the growing use of transcranial magnetic stimulation technique for the diagnosis and treatment of neurological disorders The high effectiveness of electroconvulsive therapy in the treatment of psychotic depression and the increasing numbers of patients taking treatment are, however, likely to be one of the key constraints of the market in transcranial magnetic stimulator during the forecast period.
The report presents a detailed analysis of the following key players in the global transcranial magnetic stimulator market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by Population |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Transcranial Magnetic Stimulator Market Overview
3.1 Transcranial Magnetic Stimulator Market Historical Value (2017-2023)
3.2 Transcranial Magnetic Stimulator Market Forecast Value (2024-2032)
4 Transcranial Magnetic Stimulator Market Landscape
4.1 Transcranial Magnetic Stimulator: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Transcranial Magnetic Stimulator: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Transcranial Magnetic Stimulator Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Transcranial Magnetic Stimulator Market Segmentation
6.1 Transcranial Magnetic Stimulator Market by Type
6.1.1 Market Overview
6.1.2 Deep Transcranial Magnetic Stimulator
6.1.3 Repetitive Transcranial Magnetic Stimulator
6.1.4 Others
6.2 Transcranial Magnetic Stimulator Market by Application
6.2.1 Market Overview
6.2.2 Alzheimer’s disease
6.2.3 Depression
6.2.4 Parkinson’s disease
6.2.5 Epilepsy
6.2.6 Others
6.3 Transcranial Magnetic Stimulator Market by Population
6.3.1 Adults
6.3.2 Children
6.4 Transcranial Magnetic Stimulator Market by End User
6.4.1 Research
6.4.2 Diagnostics
6.4.3 Therapeutics
6.5 Transcranial Magnetic Stimulator Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Transcranial Magnetic Stimulator Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Transcranial Magnetic Stimulator Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Transcranial Magnetic Stimulator Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Transcranial Magnetic Stimulator Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Transcranial Magnetic Stimulator Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 eNeura Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Neurosoft
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Brainsway
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 The Magstim Company Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 MAG & More GmbH
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Neuronetics
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Nexstim
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Axilum Robotics
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 neuroCare Group GmbH
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Synergy Orthopedics
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Transcranial Magnetic Stimulator - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global transcranial magnetic stimulator market reached a value of USD 1.24 billion in 2023.
The market is anticipated to grow at a CAGR of 12.7% during the forecast period of 2024-2032 to reach a value of USD 3.54 billion by 2032.
The major drivers of the industry such as an increasing prevalence of neurological disorders, like schizophrenia and other disorders, the rising geriatric population, resulting in an increase in age-related brain disorders, the growing use of transcranial magnetic stimulation technique for the diagnosis and treatment of neurological disorders are expected to aid the market growth.
The key market trend guiding the growth of the industry include the rising awareness of the product among professionals.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Deep transcranial and repetitive transcranial, among others, are the leading transcranial magnetic stimulator products in the industry.
Alzheimer's disease, Parkinson's disease, depression, and epilepsy, among others, are the major application segments of the product in the industry.
The major players in the industry are BrainsWay Ltd., Magstim, Nexstim, Inc., MagVenture, Inc., eNeura Inc., and neurocare group AG, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.